The immunosuppressed traveler: infection risks with autoimmunity and immunosuppression, vaccinations, and general travel advice

Allen, Victoria B; Longley, Nicky; Galloway, James; Bechman, Katie

doi:10.1016/b978-0-444-64217-2.00006-3

Search citation statements

Order By: Relevance

Paper Sections

Select...

Pre-travel Risk Assessment1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A simple question to start the risk assessment with is: ‘Who is this person and what will they be doing in this place at this time?’ These areas can then be considered in more detail as follows [ 5 ] ( Fig. 1 ).…”

Section: Pre-travel Risk Assessmentmentioning

confidence: 99%

Infections in immunosuppressed travellers with autoimmune inflammatory diseases—a narrative review and advice for clinical practice

Allen

Longley

2021

Rheumatology

Self Cite

View full text Add to dashboard Cite

The management of autoimmune, inflammatory diseases has been revolutionised by biological therapies. A beneficial consequence of better disease control is that more patients are well enough to travel the world. There is now a class of traveller, the significantly immunosuppressed person with autoimmune disease, with specific risks and requirements. This review introduces the concept of the pre-travel risk assessment and discusses the major vaccine-preventable and non-vaccine-preventable travel-associated infections. The challenges and controversies around vaccination and immunosuppression are reviewed with advice for clinical practice. Please also advise patients travelling abroad to wear a seat belt and use condoms.

show abstract

Section: Pre-travel Risk Assessmentmentioning

confidence: 99%